Subcutaneous versus intravenous trastuzumab for HER2-positive breast cancer: a global systematic review and meta-analysis with a cost-minimization analysis from the Chinese healthcare system perspective

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-01-07
DOI
https://doi.org/10.3389/fphar.2025.1730175
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Subcutaneous versus intravenous trastuzumab for HER2-positive breast cancer: a global systematic review and meta-analysis with a cost-minimization analysis from the Chinese healthcare system perspective

Li Zhong, Zefeng Zhu, Zheng Zeng, Yuening Cao et al.
Frontiers in Pharmacology
HER2/EGFR in Cancer Research
article

Subcutaneous versus intravenous trastuzumab for HER2-positive breast cancer: a global systematic review and meta-analysis with a cost-minimization analysis from the Chinese healthcare system perspective

Li Zhong, Zefeng Zhu, Zheng Zeng, Yuening Cao, Luqin Liao, Da Zheng, Lin Zhang, Guidong Huang, Wei Chen, Ling Zhu
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 16
Guilin Medical University (CN), Affiliated Hospital of Guilin Medical College (CN)
Natural Science Foundation of Guangxi Province
Openalex Percentile: Top 95%
HER2/EGFR in Cancer Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.